Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Ambu A/S
  6. News
  7. Summary
    AMBU B   DK0060946788

AMBU A/S

(AMBU B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 01/25 10:59:49 am
130.85 DKK   +0.65%
01/06AMBU A/S : launches aCart™ platform to strengthen single-use endoscopy offering
PU
01/04AMBU A/S : Q1 Aide-mémoire file_download
PU
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P Global 1200
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ambu A/S : Proxy form

11/15/2021 | 12:45pm EST

PROXY FORM

for Ambu A/S' annual general meeting on Tuesday, 14 December 2021 at 1:00 pm (CET)

The undersigned hereby grants proxy to attend and vote on my behalf at the convened annual general meeting in Ambu A/S, which is held on Tuesday, 14 December 2021 as provided below:

Please tick box A) or B) or C) or grant proxy online at www.ambu.com/agm:

  1. Proxy is granted to a named third party: __________________________________________________________

Please state name and address of proxy (BLOCK LETTERS)

or

  1. Proxy is granted to the Board of Directors (or order) to vote in accordance with the Board of Directors' recommendation as specified in the form below.

or

  1. Instructive proxy is granted to the Board of Directors (or order) to vote as indicated below. Please tick the relevant box 'IN FAVOUR', 'AGAINST' or 'ABSTAIN' to indicate how you want to vote.

Items on the agenda

In favour

Against

Abstain

Board of Directors'

recommendation

2.

Presentation for adoption of the annual report and consolidated

IN FAVOUR

financial statements.

3.

Presentation for adoption of the remuneration report

IN FAVOUR

4.

Proposal of the Board of Directors on the appropriation of profit

IN FAVOUR

in accordance with the adopted annual report.

5.

Approval of the directors' remuneration for the financial year

IN FAVOUR

2021/22

6.

Election of Chairman of the Board

Re-election of Jørgen Jensen

IN FAVOUR

7.

Election of Vice-chairman of the Board

Re-election of Christian Sagild

IN FAVOUR

8.

Election of other members of the Board

a) Re-election of Henrik Ehlers Wulff

b) Re-election of Britt Meelby Jensen

IN FAVOUR

c) Election of Michael del Prado

d) Election of Susanne Larsson

9.

Election of auditor:

10

Re-election of EY

IN FAVOUR

10.1.

Indemnification of members of the Board of Directors and the

IN FAVOUR

Executive Board

10.2.

Update of the remuneration policy

IN FAVOUR

10.3.

Renewal of the Board of Directors' authorization to increase the

IN FAVOUR

B share capital (article 9e of the Articles of Association)

11.

Authorization to the Chairman.

IN FAVOUR

If the proxy is dated and signed only, but otherwise not filled out, the proxy is regarded as having been granted to the Board of Directors to vote in accordance with its recommendation as specified in the form above. If the proxy is only partially filled out, the vote for items not filled out will be in accordance with the Board of Directors' recommendation.

The proxy applies to all items discussed at the annual general meeting. If new proposals for voting are made, including proposals for amendments or proposals for candidates up for voting which are not included on the agenda, the proxy holder will vote on your behalf as he or she deems proper.

The proxy applies to shares owned by the undersigned at the date of registration, determined on the basis of the number of shares held by that shareholder as registered in the register of shareholders and on any notice of ownership received by the company for the purpose of registration in the register of shareholders, but not yet registered.

Shareholder name:

Address:

City and zip code:

If any, custody account/VP reference no.:

Signature and date

This proxy form must be submitted to VP Securities A/S, Weidekampsgade 14, 2300 Copenhagen S, Denmark, by the latest Friday, 10 December 2021 at 11.59 pm (CET), either by letter or by returning this form by email to vpinvestor@vp.dk. Proxy can also be granted via VP Securities' website www.uk.vp.dk/agm or www.ambu.com/agm.

Disclaimer

Ambu A/S published this content on 15 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2021 17:44:00 UTC.


ę Publicnow 2021
All news about AMBU A/S
01/06AMBU A/S : launches aCart™ platform to strengthen single-use endoscopy offering
PU
01/04AMBU A/S : Q1 Aide-mémoire file_download
PU
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P Global 1200
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350 - Health Care
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350 - Health Care Equipment & Services (In..
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P International 700
CI
01/03AMBU A/S : Download the presentation
PU
2021AMBU A/S : Ex-dividend day for final dividend
FA
2021Ambu A/S Announces Board Appointments
CI
More news
Analyst Recommendations on AMBU A/S
More recommendations
Financials
Sales 2022 4 744 M 718 M 718 M
Net income 2022 270 M 40,9 M 40,9 M
Net Debt 2022 1 231 M 186 M 186 M
P/E ratio 2022 124x
Yield 2022 0,28%
Capitalization 32 985 M 4 999 M 4 996 M
EV / Sales 2022 7,21x
EV / Sales 2023 6,02x
Nbr of Employees 4 584
Free-Float -
Chart AMBU A/S
Duration : Period :
Ambu A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBU A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 130,00 DKK
Average target price 174,33 DKK
Spread / Average Target 34,1%
EPS Revisions
Managers and Directors
Juan-JosÚ Gonzalez Chief Executive Officer
Michael H°jgaard CFO, EVP-Global Finance, IT & Investor Relations
J°rgen Jensen Chairman
Mňns Eskil Barsne Executive VP-Global Research & Development
Henrik AnkjŠr Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
AMBU A/S-24.86%5 012
ABBOTT LABORATORIES-12.02%212 347
MEDTRONIC PLC0.73%140 116
BECTON, DICKINSON AND COMPANY3.37%74 100
HOYA CORPORATION-13.50%47 942
BAXTER INTERNATIONAL INC.0.14%43 040